Selective Inhibitors of Phosphodiesterase 4B (PDE-4B) May Provide a Better Treatment for CNS, Metabolic, Autoimmune, and Inflammatory Diseases - Abdel-Magid, Ahmed F. (ACS Med Chem Lett, 2017)